Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4218 Target Snapshot

Tegument protein VP16 · SINGLE PROTEIN · Herpes simplex virus (type 1 / strain 17)

938Compounds
7Assays
2Approved Drugs
944.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P06492. Use UniProt P06492 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P06492 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tegument protein VP16 as ChEMBL target CHEMBL4218, mapped to UniProt P06492. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tegument protein VP16
SINGLE PROTEIN · Herpes simplex virus (type 1 / strain 17)
As of 2026-09-14
ChEMBL target ID
CHEMBL4218
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P06492
Tegument protein VP16
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tegument protein VP16 is the right protein anchor across sources, using UniProt P06492 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTegument protein VP16
UniProt AccessionP06492
Component TypeProtein
Sequence Length490 aa

Tegument protein VP16

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tegument protein VP16, mapped to UniProt P06492. Sequence length is 490 aa.

Mapped IDP06492
Review nameTegument protein VP16
OrganismHerpes simplex virus (type 1 / strain 17)
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC50935.0
EC509.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1276308 9.15 EC50 0.7 Approved
CHEMBL363151 8.15 EC50 7.0 Preclinical
CHEMBL193836 6.56 EC50 272.6 Preclinical
CHEMBL1399772 5.5 IC50 3197.0 Preclinical
CHEMBL1413178 5.46 IC50 3503.0 Preclinical
CHEMBL1383315 5.4 IC50 3976.0 Preclinical
CHEMBL1893675 5.39 IC50 4102.0 Preclinical
CHEMBL1373969 5.33 IC50 4713.0 Preclinical
CHEMBL1965376 5.33 IC50 4648.0 Preclinical
CHEMBL479368 5.32 IC50 4771.0 Preclinical
Distribution

pChEMBL Value Distribution

57
5.0
1
5.5
0
6.0
1
6.5
0
7.0
0
7.5
1
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MIFEPRISTONE
CHEMBL1276308
Approved 2000
Assay Landscape

Assay Landscape

8
Total Assays
236
Tested Compounds
2
Assay Types
Functional — 7 assays, 236 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 234 4.8
assay format 2 2 8.7
Binding — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 1 6.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine